Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 13Retinoblastoma 9Mesothelioma 9Solid Tumor 7Sarcoma 6Pancreatic Neoplasms 6Lung Neoplasms 6Unspecified Childhood Solid Tumor, Protocol Specific 5Unspecified Adult Solid Tumor, Protocol Specific 5Solid Tumors 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Wilms Tumor 3Solid Tumor, Adult 3Neuroblastoma 3Colorectal Neoplasms 3Advanced Solid Tumors 3Advanced Solid Tumor 3Thymoma 2Stomach Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Osteosarcoma 2Neoplasms 2Neoplasm Metastasis 2Kidney Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2

Interventions

pembrolizumab 4toripalimab 2tislelizumab 1spartalizumab 1sintilimab 1efineptakin alfa 1camrelizumab 1atezolizumab 1Taxes 1MK 2206 1Injections 1Cyclophosphamide 1Cetuximab 1Albumin-Bound Paclitaxel 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced or Metastatic Solid Tumors × Cyclophosphamide × Other solid neoplasm × Clear all
NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Chinese PLA General Hospital

Phase 1/2 Recruiting
40 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡